Compare Moderna, Inc. (MRNA) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? Moderna, Inc. trades at $136.26 (market cap $54.14B), while First Trust NASDAQ 100 Technology Index Fund trades at $310.91. Which is the better fit depends on your goals.
| MRNA | QTEC | |
|---|---|---|
Market Cap | $54.14B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $174.38 | $335.74 |
52-Week Low | $22.36 | $207.03 |
Enterprise Value | $50.29B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $140.33, down 3.59% on the day, amid mixed signals. The stock has seen volatility, with a 143% surge over the past month driven by positive cancer vaccine trial results (Fox Business, 2026-09-06), but faces headwinds from declining revenue and persistent net losses. Technical analysis shows a bullish overall signal, with support at $138 and resistance at $145, while fundamentals reveal a challenging profit margin of -142.58% for 2026.
The outlook hinges on pipeline successes, particularly in oncology, but high valuation ratios and competitive pressures pose risks. Analyst consensus is cautious, with a $90.08 price target, reflecting skepticism despite recent clinical milestones. Investors should weigh innovation potential against financial sustainability and market sentiment shifts.
QTEC trades at $311.57, down 0.22% on the day, with a neutral technical signal overall. The ETF provides equal-weighted exposure to the technology sector, with recent analysis highlighting software industry undervaluation relative to historical averages. Moving averages indicate a bearish short-term trend, while oscillators remain neutral, suggesting limited momentum.
The outlook for QTEC hinges on broader technology sector performance, with potential upside from software valuation catch-up. Risks include market volatility and sector-specific headwinds. Investors should weigh the ETF's diversification benefits against exposure to tech sector cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
